EUVIMEDObjevte EUVIMED
Crossref

Dulcitol Selectively Inhibits Proliferation and Metastasis Related Markers in Triple‐Negative Breast Cancer: Uncovering an Unforeseen Activity

Betul Yanik, Filiz Bakar-Ates

Cell Biochemistry and Function · 2025-11 · 43 (11)

DOI: 10.1002/cbf.70134 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2025-10-28. Written by Betul Yanik and 1 co-authors. Institution: Department of Biochemistry, Ankara University, Faculty of Pharmacy, Ankara, Türkiye. Major MEDLINE topics: Cell Proliferation, Triple Negative Breast Neoplasms, Antineoplastic Agents, Biomarkers, Tumor. Cited 1 times so far (Crossref); 50 references. Funded by: This study was financially supported by Ankara University Scientific Research Council with 21L0237017 project number..

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Breast cancer remains the most commonly diagnosed cancer and a leading cause of cancer‐related mortality among women worldwide. Despite advancements in treatment, resistance and toxicity issues highlight the urgent need for novel, effective, and safer therapeutic agents. Natural compounds are increasingly explored as promising sources of anticancer candidates due to their structural diversity and bioactivity. Among these, polyols, a class of sugar alcohols, have been reported to influence cancer cell behaviour by modulating oxidative stress, metabolic pathways and apoptosis, though their precise mechanisms and therapeutic potential remain underexplored. In this study, the anticancer potential of dulcitol, a naturally occurring polyol, was investigated in breast cancer cell lines with different molecular profiles. The cytotoxic effects of dulcitol were assessed using the MTT assay in MCF‐7 (ER‐positive), MDA‐MB‐231 (triple‐negative), and MCF‐10A (non‐tumorigenic) breast cell lines. Mechanistic studies including flow cytometry‐based cell cycle analysis, apoptosis detection (Annexin V‐FITC), mitochondrial membrane potential assessment, caspase activation, and DNA damage analysis were performed on MDA‐MB‐231 cells. The expression levels of MMP‐2 and MMP‐9 genes were also evaluated using qRT‐PCR. Dulcitol exhibited selective cytotoxicity against MDA‐MB‐231 cells at concentrations ≥ 7.5 mmol/L, while showing no significant effects on MCF‐7 and MCF‐10A cells. In MDA‐MB‐231 cells, dulcitol induced G0/G1 phase cell cycle arrest and promoted apoptosis in a dose‐dependent manner. Additionally, increased caspase activity and mitochondrial depolarization were observed, indicating activation of the intrinsic apoptotic pathway. No significant DNA damage was detected; however, a significant downregulation of MMP‐2 and MMP‐9 expression suggested potential antimetastatic activity. Although the effective in vitro concentrations were relatively high, it should be noted that such levels are commonly required to reveal mechanistic effects in cell‐based systems, and pharmacokinetic data on dulcitol are currently unavailable. Therefore, the present findings should be regarded as exploratory and hypothesis‐generating, emphasizing the need for in vivo pharmacokinetic and efficacy studies to evaluate translational feasibility. In conclusion, our findings demonstrate that dulcitol selectively targets triple‐negative breast cancer cells without affecting normal or ER‐positive breast cells. Its ability to induce apoptosis and suppress metastatic gene expression highlights its promise as a potential natural therapeutic candidate for aggressive breast cancer subtypes.

Subjects

MeSH terms (MEDLINE)

Cell ProliferationTriple Negative Breast NeoplasmsAntineoplastic AgentsBiomarkers, TumorHumansApoptosisFemaleCell Line, TumorMembrane Potential, MitochondrialDrug Screening Assays, Antitumor

Author keywords

MMP‐2MMP‐9apoptosisbreast cancercytotoxicitydulcitol

Substances

Antineoplastic AgentsBiomarkers, Tumor

Authors and institutions

  • Department of Biochemistry, Ankara University, Faculty of Pharmacy, Ankara, Türkiye.
  • Ankara University, Institute of Health Sciences, Ankara, Türkiye.

Funding

  • This study was financially supported by Ankara University Scientific Research Council with 21L0237017 project number.

Cite

APA

Yanik, B., & Bakar-Ates, F. (2025). Dulcitol Selectively Inhibits Proliferation and Metastasis Related Markers in Triple‐Negative Breast Cancer: Uncovering an Unforeseen Activity. Cell Biochemistry and Function, 43(11). https://doi.org/10.1002/cbf.70134

Vancouver

Yanik B, Bakar-Ates F. Dulcitol Selectively Inhibits Proliferation and Metastasis Related Markers in Triple‐Negative Breast Cancer: Uncovering an Unforeseen Activity. Cell Biochemistry and Function. 2025;43(11). doi:10.1002/cbf.70134

BibTeX
@article{Yanik2025,
  author = {Yanik, Betul and Bakar-Ates, Filiz},
  title = {Dulcitol Selectively Inhibits Proliferation and Metastasis Related Markers in Triple‐Negative Breast Cancer: Uncovering an Unforeseen Activity},
  journal = {Cell Biochemistry and Function},
  year = {2025},
  volume = {43},
  number = {11},
  doi = {10.1002/cbf.70134}
}
Start for free →